Page 100 - ARNM-3-3

Advances in Radiotherapy
& Nuclear Medicine Cripto-1 in cancer diagnosis and therapy

stem cell pluripotency. Nat Commun. 2016;7:12589. 51. Amaral MN, Faísca P, Ferreira HA, Gaspar MM, Reis CPJC.
Current insights and progress in the clinical management of
doi: 10.1038/ncomms12589
head and neck cancer. Cancers (Basel). 2022;14(24):6079.
41. Bianco C, Rangel MC, Castro NP, et al. Role of Cripto-1
in stem cell maintenance and malignant progression. Am J doi: 10.3390/cancers14246079
Pathol. 2010;177(2):532-540. 52. Petersson F. Nasopharyngeal Carcinoma: A Review.
doi: 10.2353/ajpath.2010.100102 Netherlands: Elsevier; 2015. p. 54-73.
42. Liu Q, Cui X, Yu X, et al. Cripto-1 acts as a functional doi: 10.1053/j.semdp.2015.02.021
marker of cancer stem-like cells and predicts prognosis of 53. Wu ZR, Li G, Wu LR, Weng DS, Li XP, Yao KT. Cripto-1
the patients in esophageal squamous cell carcinoma. Mol overexpression is involved in the tumorigenesis of
Cancer. 2017;16:81. nasopharyngeal carcinoma. BMC Cancer. 2009;9:315.
doi: 10.1186/s12943-017-0650-7 doi: 10.1186/1471-2407-9-315
43. Lo RCL, Leung CON, Chan KKS, et al. Cripto-1 contributes 54. Ye Q, Li J, Wang XY, et al. In vivo and in vitro study of
to stemness in hepatocellular carcinoma by stabilizing co-expression of LMP1 and Cripto-1 in nasopharyngeal
Dishevelled-3 and activating Wnt/β-catenin pathway. Cell carcinoma. Braz J Otorhinolaryngol. 2020;86(5):617-625.
Death Differ. 2018;25(8):1426-1441.
doi: 10.1016/j.bjorl.2019.04.002
doi: 10.1038/s41418-018-0059-x
55. Li XH, Li D, Liu C, Zhang MM, Guan XJ, Fu Y. p33ING1b
44. Alowaidi F, Hashimi SM, Nguyen M, et al. Investigating the regulates acetylation of p53 in oral squamous cell carcinoma
role of CRIPTO-1 (TDGF-1) in glioblastoma multiforme via SIR2. Cancer Cell Int. 2020;20:398.
U87 cell line. J Cell Biochem. 2019;120(5):7412-7427.
doi: 10.1186/s12935-020-01489-0
doi: 10.1002/jcb.28015
56. Yoon HJ, Hong JS, Shin WJ, et al. The role of Cripto-1 in
45. Alowaidi F, Hashimi SM, Alqurashi N, Wood SA, Wei MQ. the tumorigenesis and progression of oral squamous cell
Cripto-1 overexpression in U87 glioblastoma cells activates carcinoma. Oral Oncol. 2011;47(11):1023-1031.
MAPK, focal adhesion and ErbB pathways. Oncol Lett.
2019;18(3):3399-3406. doi: 10.1016/j.oraloncology.2011.07.019
doi: 10.3892/ol.2019.10626 57. Jain A, Mallupattu SK, Thakur R, et al. Role of oncofetal
protein CR-1 as a potential tumor marker for oral squamous
46. Brandes AA, Tosoni A, Franceschi E, Reni M, Gatta G, cell carcinoma. Indian J Clin Biochem. 2021;36:288-295.
Vecht C. Glioblastoma in adults. Crit Rev Oncol Hematol.
2008;67(2):139-152. doi: 10.1007/s12291-020-00898-2
doi: 10.1016/j.critrevonc.2008.02.005 58. Daraghma H, Untiveros G, Raskind A, et al. The role of
Nodal and Cripto-1 in human oral squamous cell carcinoma.
47. Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Oral Dis. 2021;27(5):1137-1147.
Barnholtz-Sloan JS. CBTRUS statistical report: Primary
brain and other central nervous system tumors diagnosed in doi: 10.1111/odi.13640
the United States in 2011-2015. Neuro Oncol. 2018;20(suppl 59. Xu C, Yuan Q, Hu H, et al. Expression of Cripto-1 predicts
4):iv1-iv86. poor prognosis in stage I non-small cell lung cancer. J Cell
doi: 10.1093/neuonc/noy131 Mol Med. 2020;24(17):9705-9711.
48. Zhao Y, Huang W, Kim TM, et al. MicroRNA-29a activates doi: 10.1111/jcmm.15518
a multi-component growth and invasion program in 60. Huang T, Guo YZ, Yue X, et al. Cripto-1 promotes tumor
glioblastoma. J Exp Clin Cancer Res. 2019;38:1-13. invasion and predicts poor outcomes in hepatocellular
doi: 10.1186/s13046-019-1026-1 carcinoma. Carcinogenesis. 2020;41(5):571-581.
49. Tysnes BB, Sætran HA, Mork SJ, et al. Age-dependent doi: 10.1093/carcin/bgz133
association between protein expression of the embryonic 61. Hu C, Zhang Y, Zhang M, et al. Exosomal cripto-1 serves
stem cell marker cripto-1 and survival of glioblastoma as a potential biomarker for perihilar cholangiocarcinoma.
patients. Transl Oncol. 2013;6(6):732-741. Front Oncol. 2021;11:730615.
doi: 10.1593/tlo.13427 doi: 10.3389/fonc.2021.730615
50. Pilgaard L, Mortensen JH, Henriksen M, et al. Cripto-1 62. Liu N, Su C, Xue J. Application of computed tomography
expression in glioblastoma multiforme. Brain Pathol. scanning parameters combined with serum cripto-1
2014;24(4):360-370.
in the diagnosis of renal cell carcinoma. Arch Esp Urol.
doi: 10.1111/bpa.12131 2024;77(1):25-30.

Volume 3 Issue 3 (2025) 92 doi: 10.36922/ARNM025130015